Catherine Cheng is a seasoned professional currently serving as Chief of Staff to the R&D President at Legend Biotech since May 2025. Prior to this role, Catherine held the position of Director - Enterprise Strategy Management at Novo Nordisk from October 2020 to April 2025, and Director of Strategic Projects at Adare Pharmaceuticals from August 2017 to October 2020. At Adare Pharmaceuticals, Catherine led the corporate strategy planning process, achieving significant revenue and earnings growth. Previous experience includes a role as Manager of Business Insights & Analytics at Bristol-Myers Squibb, where Catherine implemented predictive analytics models that enhanced asset valuation and reduced time to market. Earlier positions at McKinsey & Company and Merck involved leading projects focused on cost reduction and process efficiency. Catherine holds a B.A. and B.S. in Biology and Biomedical Engineering from Columbia University, an MBA in Marketing and Operations Management from The Wharton School, and an MSE in Bioengineering from the University of Pennsylvania.
This person is not in any offices